ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Breast Cancer
Cancer
Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Colorectal Cancer

Prostate Cancer trials near Houston, TX, USA:

Study of AZD0754 in Participants With Metastatic Prostate Cancer (APOLLO)

of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Biological: AZD2287
Biological: AZD0754

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Houston, Texas, United States and 14 other locations

(PK), pharmacodynamics, and preliminary efficacy of multiple anti-cancer agents in participants with metastatic prostate cancer...

Enrolling
Metastatic Prostate Cancer
Drug: Palacaparib (AZD9574)
Drug: Docetaxel

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Houston, Texas, United States and 37 other locations

The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...

Enrolling
Metastatic Prostate Cancer
Drug: AZD9574
Drug: AZD0516

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Houston, Texas, United States and 51 other locations

pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007
Drug: Darolutamide

Phase 1

Janux Therapeutics

Houston, Texas, United States and 37 other locations

Recently updated

The purpose of this study is to investigate potential drug-drug interaction (DDI) between JNJ-56021927 and abiraterone acetate and between JNJ-560219...

Active, not recruiting
Metastatic Castration-Resistant Prostate Cancer
Prostatic Neoplasms
Drug: Prednisone
Drug: Abiraterone Acetate

Phase 1

Aragon Pharmaceuticals

Houston, Texas, United States and 6 other locations

Recently updated

Assessment of the safety and efficacy of HLD-0915 (JNJ-101556143) in patients with metastatic prostate cancer who have progressed o ...

Enrolling
Metastatic Prostate Cancer
Drug: JNJ-101556143 Formulation 1
Drug: JNJ-101556143 Formulation 3

Phase 1, Phase 2

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Houston, Texas, United States and 17 other locations

Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-sensitive Prostate Cancer
Drug: prednisone
Drug: PRL-02 injection

Phase 1

Astellas
Astellas

Houston, Texas, United States and 25 other locations

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...

Active, not recruiting
Prostate Cancer
Biological: placebo
Drug: valacyclovir

Phase 2

Candel Therapeutics

Tomball, Texas, United States and 22 other locations

There are many treatment options for men with various stages of prostate cancer. Some treatments work well for a while but can caus ...

Enrolling
Hormone-refractory Prostate Cancer
Drug: VIR-5500
Drug: Androgen receptor signaling inhibitor (ARSI)

Phase 1

Astellas
Astellas

Houston, Texas, United States and 25 other locations

Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...

Active, not recruiting
Prostate Adenocarcinoma
Prostate Cancer
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Houston, Texas, United States and 42 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems